Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomas

20 Jan 2017

Abstract excerpt

AIMS: Translocation renal cell carcinoma (tRCC) is a rare subtype of kidney tumour characterized by translocations involving the transcription factor TFE3 or TFEB. tRCC was introduced into the World Health Organization classification in 2004, but much is still unknown about the natural history, clinicopathological features and outcomes of the disease. The aim of this study was to describe the landscape of fusion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28106924
DOI: 10.1111/his.13167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence, clinicopathological features and fusion transcript landscape of translocation renal cell carcinomasPMID 28106924Read ↗

Gene fusion analysis in renal cell carcinoma by FusionPlex RNA‐sequencing and correlations of molecular findings with clinicopathological featuresSemantic proximity Read ↗

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular InsightsSemantic proximity Read ↗

TFE 3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosisSemantic proximity Read ↗

Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion PartnersSemantic proximity Read ↗

Identification by FFPE RNA‐Seq of a new recurrent inversion leading to RBM10‐TFE3 fusion in renal cell carcinoma with subtle TFE3 break‐apart FISH patternSemantic proximity Read ↗

Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinomaSemantic proximity Read ↗

Chameleon TFE3-translocation RCC and How Gene Partners Can Change Morphology: Accurate Diagnosis Using Contemporary ModalitiesSemantic proximity Read ↗

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinomaSemantic proximity Read ↗

Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell CarcinomasSemantic proximity Read ↗

Identification of a novel PARP14‐TFE3 gene fusion from 10‐year‐old FFPE tissue by RNA‐seqSemantic proximity Read ↗

Identification of Molecular Tumor Markers in Renal Cell Carcinomas with TFE3 Protein Expression by RNA SequencingSemantic proximity Read ↗

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.